Skip to main content
ABBV logo

ABBV · AbbVie Inc. · Executive Compensation

Track ABBV — free
$286.00 +0.36 (+0.13%)
Market Cap
$506.00B
Shares
1.77B
Volume · Oct 26 4.32M Avg daily vol (3M) 4.86M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2019
Executive Total
Richard A. Gonzalez $21,610,598
Richard Gonzalez $21,610,598
Laura J. Schumacher $15,142,787
Carlos Alban $14,406,090
Michael Severino $9,508,448
Robert Michael $8,772,853
Robert A. Michael $8,772,853
Fiscal 2018
Executive Total
Richard A. Gonzalez $21,283,587
Richard Gonzalez $21,283,587
Laura J. Schumacher $11,383,159
Carlos Alban $8,983,079
Michael Severino $8,607,359
Robert A. Michael $3,118,888
Robert Michael $3,118,888
Fiscal 2017
Executive Total
Richard A. Gonzalez $22,625,243
Richard Gonzalez $22,625,243
Laura J. Schumacher $14,979,356
Carlos Alban $12,334,988
Michael Severino $8,395,276

Executive changes

Person Change Filed
Dr. John M. Carethers Appointed 2026-10-15
Glenn F. Tilton Retired 2025-05-13
Richard A. Gonzalez Retired 2025-05-13
Glenn F. Tilton Retired 2025-02-14
Richard A. Gonzalez Retired 2025-02-14
Robert A. Michael Appointed 2025-02-14
David R. Purdue Appointed 2024-12-13
Richard A. Gonzalez Appointed 2024-02-20
Richard A. Gonzalez Retired 2024-02-20
Robert A. Michael Appointed 2024-02-20
Robert A. Michael Appointed 2024-02-20
Susan Quaggin Appointed 2023-10-12
Jennifer Davis Appointed 2023-10-12
Robert A. Michael Appointed 2023-06-29
Kevin K. Buckbee Appointed 2022-11-29
Brian L. Durkin Retired 2022-11-29

Leadership

Key facts CIK 1551152 CUSIP 00287Y109 13F (30d) 1507 filings 1452 filers Visit website Investor relations